ZENTALIS PHARMACEUTICALS INC (ZNTL)
US98943L1070 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -292.31M | -237.11M | -166.09M | -118.55M | -46.38M | |||
| Depreciation Amortization | 1.39M | 1.43M | 540.00K | 160.00K | 110.00K | |||
| Income Taxes - Deferred | -853.00K | -770.00K | 0.00 | 20.00K | N/A | |||
| Change In Working Capital | 5.86M | 13.25M | 16.56M | 7.84M | 6.51M | |||
| Taxes Paid | 140.00K | 10.00K | 20.00K | 20.00K | 20.00K | |||
| Other non cash items | 78.08M | 59.45M | -5.10M | 23.70M | 620.00K | |||
| OPERATING CASH FLOW | -207.82M | -163.75M | -154.09M | -86.83M | -39.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -583.00K | -2.55M | -6.11M | -760.00K | -350.00K | |||
| Other Investing Activity | -43.88M | -111.63M | -12.01M | -284.07M | N/A | |||
| INVESTING CASH FLOW | -44.46M | -114.18M | -18.12M | -284.83M | -350.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 237.30M | 261.04M | 179.67M | 342.02M | 81.88M | |||
| Other Financing Activity | 0.00 | 0.00 | -1.15M | 18.42M | -50.00K | |||
| FINANCING CASH FLOW | 237.30M | 261.04M | 178.52M | 360.44M | 81.83M | |||
| CHANGE IN CASH | -14.98M | -16.89M | 6.31M | -11.22M | 42.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -207.82M | -163.75M | -154.09M | -86.83M | -39.14M | |||
| Capital Expenditure | -583.00K | -2.55M | -6.11M | -760.00K | -350.00K | |||
| FREE CASH FLOW | -208.41M | -166.30M | -160.20M | -87.59M | -39.49M | |||
All data in USD